FDA approved

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

FDA approved
May 30, 2025, 14:45 | Drugs
Supriya Peshin: FDA Approved Retifanlimab Combination for 1st Line Treatment of Advanced SCAC
Supriya Peshin, Visiting Resident in Hematology and Oncology at MD Anderson Cancer Center, shared a…
Feb 27, 2025, 10:06 | Drugs
FDA Grants Priority Review to Merck’s Application for KEYTRUDA® (pembrolizumab) Plus Standard of Care as Perioperative Treatment for Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma
Sep 23, 2024, 16:26 | Blog
Tom Snow: The FDA approved our combination therapy for adults with newly diagnosed Multiple Myeloma
Olivier Nataf, Global Head of Oncology at Sanofi, shared a post by Tom Snow on…
Aug 17, 2024, 09:13 | Positive
Harpreet Singh: Exciting news in colorectal cancer treatment
Harpreet Singh, Chief Medical Officer at Precision For Medicine, shared a post on LinkedIn: "Exciting…
Aug 11, 2024, 10:17 | Blog
Carl June about the potential of using CAR T therapy to treat glioblastoma - Penn Medicine
Penn Medicine shared a post on LinkedIn: "This year could see major breakthroughs in brain…
Jun 14, 2024, 09:30 | Blog
Upcoming webinar on "Overcoming Resistance" led by Michael Wick - The START Center for Cancer Research
The START Center for Cancer Research shared on LinkedIn:       . "Don't miss our…
Jun 7, 2024, 10:04 | Insight
Jacob Adashek: Tissue is not the issue
Jacob Adashek recently shared a post by the National Cancer Institute (NCI) on Linkedin, adding:…
May 16, 2024, 16:51 | Insight
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
In the fast-growing field of oncology, we are witnessing significant advances in several treatment modalities…
Apr 22, 2024, 05:14 | Insight
Chul Kim: In-depth review of BRAF mutant NSCLC by Dr. Marcelo Negrao at Texas Lung 24 Conference
Chul Kim, Thoracic Medical Oncologist at Georgetown University, shared a post on X: "In-depth review…
Apr 19, 2024, 15:52 | Drugs
FDA approves alectinib as adjuvant treatment for ALK-positive non-small cell lung cancer based on ALINA trial
FDA, the Food and Drug Administration approved alectinib (Alecensa, Genentech, Inc.) for adjuvant treatment following…
Apr 8, 2024, 03:54 | Drugs
Paolo Tarantino: Trastuzumab deruxtecan is now FDA approved for ANY treatment-refractory HER2+ solid tumor
Paolo Tarantino, Advanced Research Fellow in the Breast Oncology Program at Dana-Farber Cancer Institute, shared…
Apr 8, 2024, 03:45 | Drugs
Vivek Subbiah: First ADC tissue agnostic drug approved!
Quoting Vivek Subbiah's post on LinkedIn: "Just in time for American Association for Cancer Research…
Mar 19, 2024, 16:03 | Drugs
FDA granted accelerated approval to ponatinib with chemotherapy for adult patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia.
FDA Oncology Center of Excellence shared on X (Twitter): "On March 19, 2024, the Food…
Feb 19, 2024, 17:05 | Drugs
Patrick Hwu: The FDA approved a groundbreaking treatment called TIL Therapy for advanced melanoma
Patrick Hwu, President and CEO at Moffitt Cancer Center, shared on LinkedIn: "Today, the FDA…
Dec 24, 2023, 18:54 | Drugs
Laurie Glimcher: Belzutifan is approved by the FDA
Laurie Glimcher, President and CEO of Dana-Farber Cancer Institute, shared on X/Twitter: "Exciting news that…
Dec 18, 2023, 03:52 | Drugs
FDA approved enfortumab vedotin-ejfv with pembrolizumab for patients with locally advanced or metastatic urothelial cancer
FDA Oncology shared on X: "On December 15, 2023, the Food and Drug Administration (FDA)…
All: 16 Posts: 1 - 100
Special Coverage